Suppr超能文献

中高危子宫内膜癌患者盆腔及腹主动脉旁淋巴结转移的风险与模式

The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.

作者信息

Rathod Praveen S, Shakuntala P N, Pallavi V R, Kundaragi Rajashekar, Shankaranand B, Vijay C R, Devi K Uma, Bafna Uttam D

机构信息

Department of Gynaecologic Oncology, Kidwai Memorial Institute of Oncology, No.5, Type AB, Block-1, Dr M H Marigowd Road, Bangalore, India 560029.

Department of Pathology, Kidwai Memorial Institute of Oncology, Dr M H Marigowd Road, Bangalore, India.

出版信息

Indian J Surg Oncol. 2014 Jun;5(2):109-14. doi: 10.1007/s13193-014-0303-x. Epub 2014 Mar 28.

Abstract

There is a continuous debate about the extent and prognostic value of retroperitoneal lymphadenectomy in endometrial cancer. Systematic pelvic and para-aortic lymphadenectomy in endometrial cancer provides a more accurate assessment of neoplastic spread and may help in better individualization of patients for adjuvant therapy. To evaluate the risk and pattern of retroperitoneal lymph nodes metastasis in patients with endometrial cancers having intermediate and high risk factors for nodal metastasis and recurrence. We conducted a prospective nonrandomized study of 62 cases of high risk endometrial cancers examined and treated at our regional cancer institute between the years 2008 and 2012. The inclusion criteria: The intermediate risk; all patients having grade 3 or undifferentiated adenocarcinomas with less than half MI and the grade 1, 2 tumors having more than half MI with tumor size >2 cm. The high risk group; all the patients having grade 3 or undifferentiated adenocarcinomas with more than half MI, the grade 1, 2 tumors with lymph vascular space invasion (LVSI) or cervical stromal invasion as depicted by pre-operative MRI. The type 2 histology uterine papillary serous, clear cell and squamous cell carcinomas. The patients staging was carried out according to the classification established by the FIGO for endometrial cancer in 2009. The Chi-square test was used to analyze the correlation between tumor grade, myometrial invasion, size of the lesion and lymph nodes metastasis and Fisher's correction done whenever the frequency distribution was less than five. The patients mean age was 58.3 (range 31 to 76 years). A total of 118 endometrial cancer patients were treated during the study period. The 56 (47.5 %) patients belonged to low risk and 62 (52.5 %) patients belonged to high risk endometrial cancers. The 52 of 62 cases were eligible for the analysis. The 10 patients' were excluded from further analysis as the post operative specimens final histopathologic examinations in nine cases revealed carcinosarcoma uterus and one case with yolk sac tumor of endometrium. The total 17(32.7 %) of 52 cases had retroperitoneal nodes metastasis; nine of 17 (52.9 %) in this group had both pelvic and para-aortic lymph nodal metastasis and one of 17 (5.9 %) had isolated para-aortic lymph nodal metastasis. The high grade tumors (grade 3) revealed 41.4 % pelvic and 20.7 % para-aortic lymph nodes metastasis and there was statistically significant higher nodal metastasis in both pelvic and para-aortic lymph nodes with increasing depth of myometrial invasion (P = 0.0119 and P = 0.0001) and increasing size of the lesion. (P = 0.04 and P = 0.0501). The intermediate and high risk endometrial cancer is associated with greater degree of lymph node metastasis. A complete surgical staging which involves extrafascial hysterectomy or a type 3 radical hysterectomy when there is a cervical involvement, along with bilateral salphingo-oophorectomy, pelvic, para-aortic lymphadenectomy and an omentectomy when indicated as in the present study, is a valuable modality of treatment in intermediate and high risk cases of endometrial cancers for determining the prognosis and appropriate categorization of these women for adjuvant therapy. It is also possible to achieve a complete surgical staging in these groups of women with acceptable morbidity when performed by a trained gynaecologic oncologist.

摘要

关于子宫内膜癌腹膜后淋巴结切除术的范围及预后价值,一直存在持续的争论。子宫内膜癌系统性盆腔及腹主动脉旁淋巴结切除术能更准确地评估肿瘤扩散情况,有助于更精准地为患者个体化制定辅助治疗方案。为评估具有淋巴结转移和复发中高危因素的子宫内膜癌患者腹膜后淋巴结转移的风险及模式。我们对2008年至2012年期间在我们地区癌症研究所检查和治疗的62例高危子宫内膜癌患者进行了一项前瞻性非随机研究。纳入标准:中危;所有3级或未分化腺癌且肌层浸润小于一半的患者,以及1、2级肿瘤且肌层浸润大于一半且肿瘤大小>2 cm的患者。高危组;所有3级或未分化腺癌且肌层浸润大于一半的患者,1、2级肿瘤伴有术前MRI显示的淋巴管间隙浸润(LVSI)或宫颈间质浸润的患者。2型组织学子宫乳头状浆液性癌、透明细胞癌和鳞状细胞癌。患者分期根据2009年国际妇产科联盟(FIGO)制定的子宫内膜癌分类标准进行。采用卡方检验分析肿瘤分级、肌层浸润、病变大小与淋巴结转移之间的相关性,当频数分布小于5时进行Fisher校正。患者平均年龄为58.3岁(范围31至76岁)。研究期间共治疗118例子宫内膜癌患者。56例(47.5%)患者属于低危子宫内膜癌,62例(52.5%)患者属于高危子宫内膜癌。62例中有52例符合分析条件。10例患者被排除在进一步分析之外,因为9例患者术后标本最终组织病理学检查显示为子宫癌肉瘤,1例为子宫内膜卵黄囊瘤。52例中共有17例(32.7%)有腹膜后淋巴结转移;该组17例中有9例(52.9%)同时有盆腔和腹主动脉旁淋巴结转移,17例中有1例(5.9%)有孤立的腹主动脉旁淋巴结转移。高级别肿瘤(3级)显示盆腔淋巴结转移率为41.4%,腹主动脉旁淋巴结转移率为20.7%,随着肌层浸润深度增加(P = 0.0119和P = 0.0001)以及病变大小增加,盆腔和腹主动脉旁淋巴结转移在统计学上均显著升高(P = 0.04和P = 0.0501)。中高危子宫内膜癌与更高程度的淋巴结转移相关。如本研究所示,完整的手术分期包括筋膜外子宫切除术或宫颈受累时的3型根治性子宫切除术,以及双侧输卵管卵巢切除术、盆腔和腹主动脉旁淋巴结切除术,并在有指征时进行大网膜切除术,对于中高危子宫内膜癌病例,是确定预后以及为这些女性进行辅助治疗适当分类的有价值的治疗方式。由训练有素的妇科肿瘤学家进行时,在这些女性群体中也能够以可接受的发病率实现完整的手术分期。

相似文献

1
The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.
Indian J Surg Oncol. 2014 Jun;5(2):109-14. doi: 10.1007/s13193-014-0303-x. Epub 2014 Mar 28.
4
A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Am J Obstet Gynecol. 2016 Jul;215(1):117.e1-7. doi: 10.1016/j.ajog.2015.12.046. Epub 2015 Dec 29.
7
8
Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
Int J Gynecol Cancer. 2014 May;24(4):697-702. doi: 10.1097/IGC.0000000000000113.
10
FIGO staging of endometrial cancer: 2023.
J Gynecol Oncol. 2023 Sep;34(5):e85. doi: 10.3802/jgo.2023.34.e85. Epub 2023 Aug 8.

引用本文的文献

5
Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma.
World J Surg Oncol. 2020 Oct 30;18(1):284. doi: 10.1186/s12957-020-02056-7.
6
Gynecological cancers: A summary of published Indian data.
South Asian J Cancer. 2016 Jul-Sep;5(3):112-20. doi: 10.4103/2278-330X.187575.

本文引用的文献

2
The role of lymphadenectomy in surgical staging of endometrial cancer.
Int J Surg Oncol. 2011;2011:814649. doi: 10.1155/2011/814649. Epub 2011 Jul 10.
4
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
Lancet. 2010 Apr 3;375(9721):1165-72. doi: 10.1016/S0140-6736(09)62002-X. Epub 2010 Feb 24.
5
Lymphadenectomy for the management of endometrial cancer.
Cochrane Database Syst Rev. 2010 Jan 20(1):CD007585. doi: 10.1002/14651858.CD007585.pub2.
6
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.
Int J Gynaecol Obstet. 2009 May;105(2):103-4. doi: 10.1016/j.ijgo.2009.02.012.
7
FIGO staging for uterine sarcomas.
Int J Gynaecol Obstet. 2009 Mar;104(3):177-8. doi: 10.1016/j.ijgo.2008.12.008. Epub 2009 Jan 9.
8
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.
Lancet. 2009 Jan 10;373(9658):125-36. doi: 10.1016/S0140-6736(08)61766-3. Epub 2008 Dec 16.
9
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.
10
Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
Acta Obstet Gynecol Scand. 2008;87(12):1361-9. doi: 10.1080/00016340802503054.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验